Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
30.16
-1.84 (-5.75%)
Nov 21, 2025, 11:59 AM HKT

HKG:2315 Statistics

Total Valuation

HKG:2315 has a market cap or net worth of HKD 12.78 billion. The enterprise value is 12.93 billion.

Market Cap12.78B
Enterprise Value 12.93B

Important Dates

The next estimated earnings date is Friday, November 28, 2025.

Earnings Date Nov 28, 2025
Ex-Dividend Date n/a

Share Statistics

HKG:2315 has 399.40 million shares outstanding. The number of shares has decreased by -0.31% in one year.

Current Share Class 110.78M
Shares Outstanding 399.40M
Shares Change (YoY) -0.31%
Shares Change (QoQ) -0.38%
Owned by Insiders (%) 13.88%
Owned by Institutions (%) 30.01%
Float 77.08M

Valuation Ratios

The trailing PE ratio is 87.69.

PE Ratio 87.69
Forward PE n/a
PS Ratio 9.79
PB Ratio 13.01
P/TBV Ratio 13.33
P/FCF Ratio 34.44
P/OCF Ratio 30.29
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 31.28, with an EV/FCF ratio of 34.83.

EV / Earnings 89.22
EV / Sales 9.90
EV / EBITDA 31.28
EV / EBIT 55.79
EV / FCF 34.83

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.69.

Current Ratio 1.89
Quick Ratio 1.51
Debt / Equity 0.69
Debt / EBITDA 1.50
Debt / FCF 1.81
Interest Coverage 3.26

Financial Efficiency

Return on equity (ROE) is 16.11% and return on invested capital (ROIC) is 10.77%.

Return on Equity (ROE) 16.11%
Return on Assets (ROA) 6.20%
Return on Invested Capital (ROIC) 10.77%
Return on Capital Employed (ROCE) 12.10%
Revenue Per Employee 999,222
Profits Per Employee 110,932
Employee Count1,117
Asset Turnover 0.48
Inventory Turnover 33.60

Taxes

In the past 12 months, HKG:2315 has paid 19.10 million in taxes.

Income Tax 19.10M
Effective Tax Rate 11.65%

Stock Price Statistics

The stock price has increased by +424.00% in the last 52 weeks. The beta is 0.10, so HKG:2315's price volatility has been lower than the market average.

Beta (5Y) 0.10
52-Week Price Change +424.00%
50-Day Moving Average 27.04
200-Day Moving Average 19.35
Relative Strength Index (RSI) 60.64
Average Volume (20 Days) 556,304

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2315 had revenue of HKD 1.30 billion and earned 144.88 million in profits. Earnings per share was 0.36.

Revenue1.30B
Gross Profit 1.04B
Operating Income 267.32M
Pretax Income 163.97M
Net Income 144.88M
EBITDA 419.11M
EBIT 267.32M
Earnings Per Share (EPS) 0.36
Full Income Statement

Balance Sheet

The company has 533.47 million in cash and 673.00 million in debt, giving a net cash position of -139.54 million or -0.35 per share.

Cash & Cash Equivalents 533.47M
Total Debt 673.00M
Net Cash -139.54M
Net Cash Per Share -0.35
Equity (Book Value) 982.46M
Book Value Per Share 2.45
Working Capital 458.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 421.96 million and capital expenditures -50.86 million, giving a free cash flow of 371.09 million.

Operating Cash Flow 421.96M
Capital Expenditures -50.86M
Free Cash Flow 371.09M
FCF Per Share 0.93
Full Cash Flow Statement

Margins

Gross margin is 79.48%, with operating and profit margins of 20.48% and 11.10%.

Gross Margin 79.48%
Operating Margin 20.48%
Pretax Margin 12.56%
Profit Margin 11.10%
EBITDA Margin 32.12%
EBIT Margin 20.48%
FCF Margin 28.44%

Dividends & Yields

HKG:2315 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.31%
Shareholder Yield 0.31%
Earnings Yield 1.13%
FCF Yield 2.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2315 has an Altman Z-Score of 1.4 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.4
Piotroski F-Score 7